Dr. Kirsten M. Leu
Claim this profileNebraska Methodist Hospital
Area of expertise
Breast Cancer
Kirsten M. Leu has run 7 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Kirsten M. Leu has run 4 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Nebraska Methodist Hospital
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
Clinical Trials Kirsten M. Leu is currently running
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting
2 awards
Phase 3
6 criteria
More about Kirsten M. Leu
Clinical Trial Related
2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kirsten M. Leu has experience with
- Paclitaxel
- Radiation Therapy
- Olaparib
- MGC018
- MGA012
- INBRX-109
Breakdown of trials Kirsten M. Leu has run
Breast Cancer
Breast cancer
Soft Tissue Sarcoma
Soft tissue sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kirsten M. Leu specialize in?
Kirsten M. Leu focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Kirsten M. Leu currently recruiting for clinical trials?
Yes, Kirsten M. Leu is currently recruiting for 2 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Kirsten M. Leu has studied deeply?
Yes, Kirsten M. Leu has studied treatments such as Paclitaxel, Radiation Therapy, Olaparib.
What is the best way to schedule an appointment with Kirsten M. Leu?
Apply for one of the trials that Kirsten M. Leu is conducting.
What is the office address of Kirsten M. Leu?
The office of Kirsten M. Leu is located at: Nebraska Methodist Hospital, Omaha, Nebraska 68114 United States. This is the address for their practice at the Nebraska Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.